Correction

Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial (vol 165, pg 573, 2017)

Journal

BREAST CANCER RESEARCH AND TREATMENT
Volume 175, Issue 1, Pages 265-266

Publisher

SPRINGER
DOI: 10.1007/s10549-018-05105-8

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Recommended

No Data Available
No Data Available